Neurocrine Bioscienc (NBIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NBIX | TAK | ZTS | ONC | UTHR |
| Company | Neurocrine Bioscienc | Takeda Pharmaceutical Ltd ADR | Zoetis Inc Cl A | Beone Medicines Ltd | United Therapeutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NASDAQ | NASDAQ |
| Open | 131.74 | 18.22 | 116.89 | 284.70 | 583.62 |
| High | 133.99 | 18.59 | 118.03 | 295.93 | 599.00 |
| Low | 131.53 | 18.18 | 115.66 | 283.48 | 571.71 |
| Latest | 132.64 | 18.42 | 117.63 | 295.25 | 585.87 |
| Change | +3.92 | +0.15 | +1.30 | +11.17 | -2.49 |
| % Change | +3.05% | +0.82% | +1.12% | +3.93% | -0.42% |
| Volume | 389,862 | 3,231,191 | 1,608,826 | 140,506 | 475,285 |
| 20-Day Average Volume | 948,786 | 2,673,453 | 4,209,347 | 223,114 | 661,000 |
| Previous Close | 128.72 | 18.27 | 116.33 | 284.08 | 588.36 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 129.74 | 18.06 | 118.19 | 287.91 | 530.53 |
| 20-Day Raw Stochastic | 76.23% | 86.77% | 30.71% | 60.25% | 82.73% |
| 20-Day Relative Strength | 51.64 | 57.90 | 44.59 | 44.85 | 65.75 |
| Weighted Alpha | +24.57 | +32.20 | -24.92 | +13.13 | +90.24 |
| Today's Opinion | 56% Sell | 100% Buy | 88% Sell | 56% Sell | 100% Buy |
| Previous Opinion | 88% Sell | 100% Buy | 88% Sell | 72% Sell | 100% Buy |
| Last Month's Opinion | 88% Sell | 100% Buy | 24% Sell | 24% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.64% since 03/24/26 | +2.33% since 03/24/26 | +1.33% since 03/24/26 | +6.67% since 03/24/26 | +9.87% since 03/24/26 |
| Low | 128.02 on 03/27/26 | 17.87 on 03/27/26 | 113.29 on 03/27/26 | 272.02 on 03/26/26 | 520.97 on 03/27/26 |
| High | 133.74 on 03/31/26 | 18.59 on 03/31/26 | 118.58 on 03/26/26 | 295.47 on 03/31/26 | 607.89 on 03/30/26 |
| 1-Month | |||||
| %Chg | +0.20% since 02/27/26 | -1.54% since 02/27/26 | -10.40% since 02/27/26 | -7.23% since 02/27/26 | +15.96% since 02/27/26 |
| Low | 125.11 on 03/24/26 | 17.51 on 03/03/26 | 113.29 on 03/27/26 | 271.47 on 03/24/26 | 471.29 on 03/06/26 |
| High | 134.83 on 03/04/26 | 18.59 on 03/31/26 | 130.05 on 03/02/26 | 315.00 on 03/02/26 | 607.89 on 03/30/26 |
| 3-Month | |||||
| %Chg | -8.77% since 12/26/25 | +17.96% since 12/26/25 | -6.94% since 12/26/25 | -5.86% since 12/26/25 | +15.21% since 12/26/25 |
| Low | 122.14 on 02/12/26 | 15.48 on 01/05/26 | 113.29 on 03/27/26 | 271.47 on 03/24/26 | 455.63 on 01/20/26 |
| High | 145.51 on 12/29/25 | 18.82 on 02/23/26 | 132.49 on 02/12/26 | 372.73 on 02/24/26 | 607.89 on 03/30/26 |
| 6-Month | |||||
| %Chg | -6.68% since 09/26/25 | +25.24% since 09/26/25 | -18.14% since 09/26/25 | -9.81% since 09/26/25 | +35.05% since 09/26/25 |
| Low | 122.14 on 02/12/26 | 12.99 on 10/30/25 | 113.29 on 03/27/26 | 271.47 on 03/24/26 | 409.07 on 10/28/25 |
| High | 160.18 on 12/08/25 | 18.82 on 02/23/26 | 148.79 on 10/03/25 | 385.22 on 11/17/25 | 607.89 on 03/30/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 12,918,724 | 58,142,616 | 49,106,152 | 31,169,258 | 25,786,638 |
| Shares Outstanding, K | 100,363 | 3,182,409 | 422,128 | 109,720 | 43,828 |
| Annual Sales | 2,860,500,000 | 30,238,240,000 | 9,467,000,000 | 5,343,030,000 | 3,182,700,000 |
| Annual Net Income | 478,600,000 | 712,320,000 | 2,673,000,000 | 286,930,000 | 1,334,700,000 |
| Last Quarter Sales | 805,500,000 | 7,736,500,000 | 2,387,000,000 | 1,498,170,000 | 790,200,000 |
| Last Quarter Net Income | 153,700,000 | 672,830,000 | 603,000,000 | 66,500,000 | 364,300,000 |
| 60-Month Beta | 0.32 | 0.01 | 0.95 | 0.53 | 0.84 |
| Per-Share Information | |||||
| Most Recent Earnings | 1.88 on 02/11/26 | 0.48 on 01/29/26 | 1.48 on 02/12/26 | 0.58 on 02/26/26 | 7.70 on 02/25/26 |
| Latest Earnings Date | 05/04/26 | 05/14/26 | 05/05/26 | 05/06/26 | 04/29/26 |
| Most Recent Dividend | N/A | 0.252 on 09/30/25 | 0.530 on 01/20/26 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 09/30/25 | 04/20/26 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 27.84 | 11.19 | 17.66 | 75.88 | 18.74 |